As both Zeb1 and Snail1 induction have been associated with EMT and drug resistance63, and as Zeb1 is also a critical component of tumor cell plasticity64, it is not surprising that the down-regulation of these would correlate with increased sensitivity to anti-cancer agents. The gene discussed is SNAI1; the disease is cancer.